latest articles

Boston Sci, Medtronic Weigh In on Possible FDA Changes

Following a harsh review of the FDA system under which most medical devices are approved for market, Boston Scientific said that it "believe[s] in the strength of the 510(k) process," and Medtronic said it supports regulatory changes that are "in the best interest of patients, including ensuring that innovative therapies reach the market."

Central Corridor Businesses: Loans Aren’t Enough

The amount available in loans for businesses that are adversely affected by the construction of the Central Corridor light-rail line was boosted to $4 million in April, but some say it's not enough; however, only 13 of the roughly 550 businesses that qualify for a loan had applied for one as of August 1. />